InsiderTrades

Form 4 for MET MetLife

Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001099219-22-000035 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-02-24 2022-02-22 MET Khalaf Michel Pres, CEO, Dir A - Grant — +227.9K 172.5K New —
D 2022-02-24 2022-02-22 MET Khalaf Michel Pres, CEO, Dir F - Tax $68.96 -108.1K 263.8K -29% -$7.45M
D 2022-02-24 2022-02-22 MET Khalaf Michel Pres, CEO, Dir A - Grant $0.00 +85.5K 85.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-22 A A 199,371 — 371,881 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
2 Common Common Stock 2022-02-22 A A 28,495 — 172,510 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2022-02-22 F D 108,077 $68.96 263,804 D — —
4 Derivative Employee Stock Options (right to buy) 2022-02-22 A A 85,472 $0.00 85,472 D $68.96 · — to 2032-02-21 85,472 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.